Antiphospholipids in hemodialysis patients: Relationship between lupus anticoagulant and thrombosis

Kidney International

Volumn 48, Issue 3, 1995, Pages 794-800

  Brunet, Philippe ^a   Aillaud, Marie Françoise ^a   San Marco, Marielle ^a   Philip Joet, Christine ^a   Dussol, Bertrand ^a   Bernard, Dominique ^a   Juhan Vague, Irene ^a   Berland, Yvon ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADULT; AGED; ARTICLE; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOSIS;

EID: 0029093304     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1995.352     Document Type: Article

References (39)

1. HARRIS EN, ASHERSON RA, GHARAVI AE, MORGAN SH, DERUE G, HUGHES GRV: Thrombocytopenia in SLE and related autoimmune disorders: Association with anticardiolipin antibody. Br J Haematol 59:227-230, 1985
2. HARRIS EN: Antiphospholipid antibodies. Br J Haematol 74:1-9, 1990
3. MACKWORTH-YOUNG C: Antiphospholipid antibodies: More than just a disease marker? Immunol Today 11:60-65, 1990
4. ALARCON-SEGOVIA D, SANCHEZ-GUERRERO J: Primary antiphospholipid syndrome. J Rheumatol 16:482-488, 1989
5. ASHERSON RA, KHAMASHTA MA, ORDI-ROS J, DERKSEN RHWM, MACHIN SJ, BAROUINERO J, OUTT HH, HARRIS EN, PHIL M, VILARDELL-TORRES M, HUGHES GRV: The "primary" antiphospholipid syndrome: Major clinical and serologic features. Medicine 68: 366-374, 1989
6. BICK RL, BAKER WF: Antiphospholipid and thrombosis syndromes. Semin Thromb Hemost 20:3-15, 1994
7. AMIGO MC, GARCIA-TORRES R, ROBLES M, BOCHICCHIO T, REYES PA: Renal involvement in primary antiphospholipid syndrome. J Rheumatol 19:1181-1185, 1992
8. D'AGATI V, KLINIS C, WILLIAMS G, APPEL GB: Anti-cardiolipin antibody and renal disease: A report of three cases. JASN 1:777-784, 1990
9. MANDREOLI M, ZUCCHELLI P: Renal vascular disease in patients with primary antiphospholipid antibodies. Nephrol Dial Transplant 8:1277-1280, 1993
10. GARCIA-MARTIN F, DE ARRIDA G, CARRASCOSA T, MOLDENHAUER F, MARTIN-ESCOBAR E, VAL J, SAIZ F: Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease. Nephrol Dial Transplant 6:543-547, 1991
11. GRÖNHAGEN-RISKA C, TEPPO AM, HELANTERA A, HONKANEN E, JULKUNEN H: Raised concentrations of antibodies to cardiolipin in patients receiving dialysis. Br Med J 300:1696-1697, 1990
12. QUEREDA C, PARDO A, LAMAS S, OROFINO L, CARCIA-AVELLO A, MARCEN R, TERUEL JL, ORTUNO J: Lupus-like in vitro anticoagulant activity in end-stage renal disease. Nephron 49:39-44, 1988
13. SITTER T, SCHIFFL H: Anticardiolipin antibodies in patients on regular hemodialysis: An epiphenomenon? Nephron 64:655-656, 1993
14. CHEW SL, LINS RL, DAELEMANS R, ZACHEE P, DE CLERCK LS, VERMYLEN J: Are antiphospholipid antibodies clinically relevant in dialysis patients? Nephrol Dial Transplant 14:1194-1198, 1992
15. PAGE B, ZINGRAFF J, BOURQUELOT P: Clotting of vascular access in dialysis patients associated to anticardiolipin antibodies. (abstract) Kidney Int 42:223, 1992
16. KIRSCHBAUM B, MULLINAX F, CURRY N, MALLORY J: Association between anticardiolipin antibody and frequent clotting problems in hemodialysis patients. (abstract) JASN 2:332, 1991
17. EXNER T, SAHMAN N, TRUDINGER B: Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid-coated polystyrene column. Biochem Biophys Res Commun 155:1001-1007, 1988
18. ROSOVE MH, BREWER PMC, RUNGE A, HIRJI K: Simultaneous lupus anticoagulant and anticardiolipin assays and clinical detection of antiphospholipids. Am J Hematol 32:148-149, 1989
19. RAUCH J, JANOFF AS: The nature of antiphospholipids antibodies. J Rheumatol 19:1782-1785, 1992
20. ALVING BM, BANERJI B, FOGLER WE, ALVING CR: Lupus anticoagulant activities of murine monoclonal antibodies to liposomal phosphatidylinositol phosphate. Clin Exp Immunol 69:403-408, 1987
21. LOVE PE, SANTORO SA: Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 112:682-698, 1990
22. WORKING GROUP ON HEMOSTASIS OF THE SOCIETE FRANÇAISE DE BIOLOGIE CLINIQUE: Comparison of a standardized procedure with current laboratory practices for the detection of lupus anticoagulant in France. Thromb Haemostas 70:781-786, 1993
23. ROSNER E, PAUZNER R, LUSKY A, MODAN M, MANY A: Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemostas 57:144-147, 1987
24. HARRIS EN, GHARONI AE, PATEL SP, HUGHES GRV: Evaluation of the anticardiolipin antibody test: Report of an international workshop held 4 April 1986. Clin Exp Immunol 68:215-222, 1987
25. PHILLIPS AO, JONES HW, HAMBLEY H, HILLIS AN, HENDRY BM: Prevalence of lupus anticoagulant and anticardiolipin antibodies in haemodialysis patients. Nephron 65:350-353, 1993
26. MESSMORE H, FABBRINI N, HOPPENSTEADT D, LARACH F, FAREED J: Lupus anticoagulant assays. Semin Thromb Hemost 20:79-88, 1994
27. EXNER T: Some recent developments with lupus anticoagulants. Blood Coag Fibrinol 5:281-289, 1994
28. LAURELL AB, NILSSON IM: Hypergammaglobulinemia, circulating anticoagulant and biologic false positive Wassermann reaction: A study in two cases. J Lab Clin Med 49:694-707, 1957
29. HARRIS EN, GHARAVI AE, LOIZOU S, DERUE G, CHAN JK, PATEL BM, MACKWORTH-YOUNG CG, BUNN CC, HUGHES GRV: Crossreactivity of antiphospholipid antibodies. J Clin Lab Immunol 16:1-6, 1985
30. CARROLL P, STAFFORD D, SCHWARTZ RS, STOLLAR BD: Murine monoclonal anti-DNA autoantibodies bind to endogenous bacteria. J Immunol 135:1086-1090, 1985
31. GARCIA-MARTIN F, DE ARRIBA G, SANCHEZ M, PIQUERAS JA, JARILLO MD: Evolution of anticardiolipin antibodies in haemodialysis patients. (abstract) Nephrol Dial Transplant 8:989, 1993
32. SWEDBERG SH, BROWN BG, SIGLEY R, WIGHT TN, GORDON D, NICHOLLS SC: Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients: Clinical, immunocytochemical, light and electron microscopic assessment. Circulation 80:1726-1736, 1989
33. DISKIN CJ, STOKES TJ, PENNELL AT: Pharmacologic intervention to prevent hemodialysis vascular access thrombosis. Nephron 64:1-26, 1993
34. WATSON KV, SCHORER AE: Lupus anticoagulant inhibition of in vitro prostacyclin release is associated with a thrombosis-prone subset of patients. Am J Med 90:47-53, 1991
35. FREYSSINET JM, WIESEL ML, GAUCHY J, BONEU B, CAZENAVE JP: An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity-A mechanism for thrombosis. Thromb Haemost 55:309-312, 1986
36. SANFELIPPO MJ, DRAYNA CJ: Prekallikrein inhibition associated with the lupus anticoagulant. A mechanism of thrombosis. Am J Clin Pathol 77:275-279, 1982
37. COSGRIFF TM, MARTIN BA: Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis. Arthr Rheum 24:94-96, 1981
38. KHAMASHTA MA, HARRIS EN, GHARAVI AE, DERUE G, GIL A, VAZQUEZ JJ, HUGHES GRV: Immune mediated mechanism for thrombosis: Antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis 47:849-854, 1988
39. GALLI M, COMFURIUS P, MAASSEN C, HEMKER HC, DE BAETS MH, VAN BREDA-VRIESMAN PJC, BARBUI T, ZWAAL RFA, BEVERS EM: Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335:1544-1547, 1990